rituximab
aeterna zentaris
['ritux', 'lymsm', 'lymphoma', 'aeterna']
long-term extension of ardeshna 2014 study's watch &amp; wait arm (~13 years of f/u!). w&amp;w had shortest ttnt, but no difference in tt2t, transformation, cause-specific survival, spms, or os between w&amp;w, ritux induction, or ritux induction + maint. w&amp;w still preference. #lymsm #ash22 
#lymsm & #mmsm hematologist & patient-reported outcomes researcher @CUHematology. Founder of https://t.co/kN6qeGXfg5, @inTrainingDoc & @inHouseMag. ??????